Administration Agreements in the Pharmaceuticals Industry

8 Contracts & Agreements
Browse by Company
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Daytrana, the first and only transdermal patch approved by the United States Food & Drug Administration (FDA) for the treatment of ADHD
Administration Agreements
NOVEN PHARMACEUTICALS INC
Pharmaceuticals
2009
Letter Agreement re: Amendment to Tranche C Commitment, dated May 23, 2022, by and among Marinus Pharmaceuticals, Inc., as Borrower, Oaktree Fund Administration, LLC, as...
Administration Agreements
MARINUS PHARMACEUTICALS INC
Pharmaceuticals
2022
Memorandum of Agreement between Bright Green Corporation and the Department of Justice, Drug Enforcement 7 Administration
Administration Agreements
Bright Green Corp
Pharmaceuticals
2022
Memorandum of Agreement between Bright Green Corporation and the Department of Justice, Drug Enforcement 7 Administration
Administration Agreements
Bright Green Corp
Pharmaceuticals
2022
Daytrana, the first and only transdermal patch approved by the United States Food & Drug Administration (FDA) for the treatment of ADHD
Administration Agreements
NOVEN PHARMACEUTICALS INC
Pharmaceuticals
2009
Daytrana, the first and only transdermal patch approved by the United States Food & Drug Administration (FDA) for the treatment of ADHD
Administration Agreements
NOVEN PHARMACEUTICALS INC
Pharmaceuticals
DE
2009
Daytrana, the first and only transdermal patch approved by the United States Food & Drug Administration (FDA) for the treatment of ADHD
Administration Agreements
NOVEN PHARMACEUTICALS INC
Pharmaceuticals
DE
2009
/s/ Fredric I. Storch Date: October 13, 2006 Fredric I. Storch Senior Director, Human Resources and Administration Accepted by: /s/ Eric Liebler Date: October 16, 2006 Eric Liebler
Administration Agreements
QUESTCOR PHARMACEUTICALS INC
Pharmaceuticals
2006